Skip to content
Beacon

OSCXDefiance Daily Target 2x Long OSCR ETF

Take a betNewRanked #661 of 775 in this goal

Seeks daily investment results of 200% of the daily percentage change in Oscar Health, Inc. Class A share price.

By Defiance ETFs LLC · Launched 2025

Annual Cost

1.31%

#5,345 of 5,562 · expensive

Fund Size

$8M

#4,852 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

9 months

#4,782 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$13,005+30.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Leveraged

Sector

Health care

What it actually holds

By weight

Concentration

Top 6 holdings = 15.2% of fund✓ well diversified

TREASURY BILL
8.2%
N/A
3.4%
N/A
2.8%
First American Government Obli
1.8%
N/A
-0.3%
N/A
-0.7%

Asset allocation

Stocks
201.4%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-84.5%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Seeks daily investment results of 200% of the daily percentage change in Oscar Health, Inc. Class A share price.
Strategy
Actively managed ETF that uses derivatives, including swaps and options, to achieve 2x daily exposure to Oscar Health, Inc. Rebalances daily to maintain leverage, primarily using short-dated in-the-money call options. The strategy is focused on achieving this objective for a single trading day.
Inception date
September 24, 2025
Fund family
Defiance ETFs LLC

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Leveraged single-stock ETF — documented structural drag

Single-stock leveraged ETFs magnify one stock's daily move. Research on these products (Bessembinder et al., 2024) finds 56% posted negative absolute returns over one year, with ~9.5% annual drag versus the underlying stock. Daily rebalancing plus financing costs work against the investor on any holding period longer than a few days.

Source: Bessembinder, Cooper, Zhang — 'Leveraged Single-Stock ETFs' (SSRN 2024)

Why we flagged this: strategy=leveraged + single_stock_wrapper

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed OSCX. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-20